These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients]. Ginzburg TS; Iakimets VP Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638 [No Abstract] [Full Text] [Related]
45. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis]. Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331 [No Abstract] [Full Text] [Related]
46. [Dynamics of the appearance and persistence of elimination of mycobacteria and their significance (report)]. Barbu Z; Bungetianu G; Bogdănescu V Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(2):93-100. PubMed ID: 181831 [No Abstract] [Full Text] [Related]
47. Tuberculosis in the pediatric population of Houston, Texas. Starke JR; Taylor-Watts KT Pediatrics; 1989 Jul; 84(1):28-35. PubMed ID: 2500637 [TBL] [Abstract][Full Text] [Related]
48. [The nature of bacterial shedding and its effect on treatment outcome in newly detected patients with destructive pulmonary tuberculosis]. Omarov TO; Krivtsova AE; Kumisbaeva BT Probl Tuberk; 1988; (8):19-20. PubMed ID: 2974156 [No Abstract] [Full Text] [Related]
49. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria]. Fomicheva NI; Terentieva AS Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645 [No Abstract] [Full Text] [Related]
50. [Treatment and outcomes of disseminated pulmonary tuberculosis]. Rzhavskov IV; Lishchinskii AB; Znosenko VA Probl Tuberk; 1997; (1):40-1. PubMed ID: 9162924 [TBL] [Abstract][Full Text] [Related]
51. [A year's results at a bacteriological tuberculosis laboratory. The importance of atypical mycobacteria]. Wiesmann E; Blazso A; Natterer-Balogh C Schweiz Med Wochenschr; 1968 Mar; 98(12):441-4. PubMed ID: 4973283 [No Abstract] [Full Text] [Related]
52. [Antibacterial therapy of pulmonary tuberculosis caused by Mycobacterium bovis]. Naubet'iarova AN Probl Tuberk; 1976 Nov; (11):34-7. PubMed ID: 798185 [No Abstract] [Full Text] [Related]
54. [Tuberculosis, does it always come out right?]. Steensma JT Ned Tijdschr Geneeskd; 1986 Jan; 130(4):145-7. PubMed ID: 3513030 [No Abstract] [Full Text] [Related]
56. [The Mycobacteria Working Group: Investigation of resistance of tuberculosis bacteria in Germany 1991 and 1992]. Urbanczik R Pneumologie; 1994 Jan; 48(1):28-9. PubMed ID: 8153116 [TBL] [Abstract][Full Text] [Related]
57. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes]. Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554 [TBL] [Abstract][Full Text] [Related]
58. [New cases of pulmonary tuberculosis treatment within DOTS strategy]. Zhangireev AA; Ismailov ShSh; Berikova EM Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979 [TBL] [Abstract][Full Text] [Related]
59. [Recommendations for the therapy of tuberculosis]. Eule H; Ganguin HG Z Erkr Atmungsorgane; 1984; 163(1):80-91. PubMed ID: 6485398 [No Abstract] [Full Text] [Related]
60. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors]. García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]